X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

DoKaSch Temperature Solutions and ANA sign master rental agreement

Content Team by Content Team
21st February 2023
in News, Packaging & Logistic
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

All Nippon Airways (ANA), the Japanese largest airline, and DoKaSch Temperature Solutions have signed a Master Rental Agreement. The German specialist for active temperature-controlled packaging solutions is henceforth providing its Opticooler containers to ANA’s PRIO PHARMA, a dedicated product for pharmaceuticals, and PRIO TEMP, a temperature-controlled product for non-pharmaceuticals.

By combining ANA’s strong global network with the extremely high reliability and safety of the Opticooler, Japan’s fast-growing pharma and biotech industry gains further important and life-saving access to secure cold chains.

ANA, founded in 1952, is the only combination carrier in Japan with both passenger and freighter aircrafts operating global flights to more than 90 airports from its hubs at Narita and Haneda airport. ANA has been reinforcing its pharmaceuticals transport and started providing PRIO PHARMA in 2012 while acquiring the IATA CEIV certification in 2017 as the first Japanese airline.

The MRA now provides access to DoKaSch TS’s globally available container fleet. The temperature-controlled packaging solution is available in two sizes: as Opticooler RAP, providing space for five euro pallets and as RKN for one pallet. Redundant systems for electrification and full air-conditioning enable precise heating and cooling without dry ice. Thus, they are able to transport valuable and sensitive pharmaceuticals while avoiding temperature excursions on an extremely high level and with high independence of outside conditions.

Dai Yuasa, vice president of global marketing, cargo marketing & services, of All Nippon Airways underlines that “Securing cold chains are becoming increasingly relevant as Japan’s pharma and biotech industry is growing strong. By introducing the active temperature-controlled Opticooler and with very high level of reliability and safety, we would like to enhance our service level to meet our valued customers’ increasing demand to secure cold chains.”

Andreas Seitz, managing director of DoKaSch Temperature Solutions, adds: “Japan’s strong pharmaceutical and biotech industry continues to strengthen its relevance in the entire Asia-Pacific region as well as globally. With ANA, we are gaining a strong partner with whom we can further expand our Opticooler network both to serve the increasing demand of secure, fast and responsive cold chains in the important Asian market. Together with the opening of our new service station in Narita and the founding of our own Japan subsidiary, the Master Rental Agreement with ANA is another important step in providing Japanese customers in particular with a reliable option for temperature-controlled transports.”

DoKaSch is a family-owned supplier of loading equipment to the global aviation industry. With almost 30 years of experience, DoKaSch has acquired a far-reaching set of skills to develop, manufacture, maintain and market all sorts of unit load devices (ULD) for the transportation of goods and luggage in aircrafts around the world.

Previous Post

WHO grants prequalification GC Biopharma's varicella vaccine, Barycela

Next Post

Canada's National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Canada's National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero

Canada's National Carrier Air Canada Cargo and the Cool Tech Company ColdChase join Pharma.Aero

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In